Are we losing the battle against cardiometabolic disease? the case for a paradigm shift in primary prevention

BMC Public Health

Volumn 9, Issue , 2009, Pages

  Kraushaar, Lutz E ^a   Krämer, Alexander ^a  

^a BIELEFELD UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; DIABETES MELLITUS; EARLY DIAGNOSIS; ECONOMICS; FEMALE; HEALTH; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH PROMOTION; HUMAN; MALE; MASS SCREENING; NEEDS ASSESSMENT; ORGANIZATION AND MANAGEMENT; PREVALENCE; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL;

CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; DIABETES MELLITUS; EARLY DIAGNOSIS; FEMALE; HEALTH PLANNING; HEALTH PROMOTION; HUMANS; MALE; MASS SCREENING; NEEDS ASSESSMENT; PREVALENCE; PRIMARY PREVENTION; PROGRAM EVALUATION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; WORLD HEALTH;

EID: 61849145651     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-64     Document Type: Review

References (53)

1. The Global Burden of Cardiovascular Disease. S Ounpuu S Anand S Yusuf, Medscape Cardiology 2002 4 1 http://www.medscape.com/viewarticle/420877
2. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. S Yusuf S Reddy S Ounpuu S Anand, Circulation 2001 104 22 2746 53 10.1161/hc4601.099487 11723030
3. Preventing Chronic Disease: a vital investment. WHO, World Health Organization 2005 200
4. Spending and service use among people with the fifteen most costly medical conditions, 1997. JW Cohen NA Krauss, Health Aff (Millwood) 2003 22 2 129 38 10.1377/hlthaff.22.2.129 12674416
5. Primary prevention of diabetes mellitus. J Tuomilehto E Wolf, Diabetes Care 1987 10 2 238 248 10.2337/diacare.10.2.238 3556107
6. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. RJ Sigal GP Kenny DH Wasserman C Castaneda-Sceppa RD White, 2006 29 16732040
7. Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline. JL Rosenzweig E Ferrannini SM Grundy SM Haffner RJ Heine ES Horton R Kawamori, J Clin Endocrinol Metab 2008 93 10 3671 3689 18664543 10.1210/jc.2008-0222
8. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. WC Knowler E Barrett-Connor SE Fowler RF Hamman JM Lachin EA Walker DM Nathan, N Engl J Med 2002 346 6 393 403 11832527 10.1056/NEJMoa012512
9. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. K Kosaka M Noda T Kuzuya, Diabetes Res Clin Pract 2005 67 2 152 62 10.1016/j.diabres.2004.06.010 15649575
10. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. XR Pan GW Li YH Hu JX Wang WY Yang ZX An ZX Hu J Lin JZ Xiao HB Cao PA Liu XG Jiang YY Jiang JP Wang H Zheng H Zhang PH Bennett BV Howard, Diabetes Care 1997 20 4 537 44 10.2337/diacare.20.4.537 9096977
11. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. J Tuomilehto J Lindstrom JG Eriksson TT Valle H Hamalainen P Ilanne-Parikka S Keinanen-Kiukaanniemi M Laakso A Louheranta M Rastas V Salminen M Uusitupa, N Engl J Med 2001 344 18 1343 50 10.1056/NEJM200105033441801 11333990
12. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. J Lindstrom A Louheranta M Mannelin M Rastas V Salminen J Eriksson M Uusitupa J Tuomilehto, Diabetes Care 2003 26 12 3230 6 10.2337/diacare.26.12.3230 14633807
13. Impact of Intensive Lifestyle and Metformin Therapy on Cardiovascular Disease Risk Factors in the Diabetes Prevention Program. The Diabetes Prevention Program Research, G, Diabetes Care 2005 28 4 888 894 15793191 10.2337/diacare.28.4.888
14. Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring. C Anderwald G Pfeiler P Nowotny M Anderwald-Stadler M Krebs MG Bischof M Kozakova A Luger G Pacini M Roden W Waldhausl, Eur J Clin Invest 2008 38 4 227 37 10.1111/j.1365-2362.2008.01932.x 18339003
15. Family history, diabetes, and other demographic and risk factors among participants of the National Health and Nutrition Examination Survey 1999-2002. AM Annis MS Caulder ML Cook D Duquette, Prev Chronic Dis 2005 2 2 A19 15888230
16. Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. AB Goldfine C Bouche RA Parker C Kim A Kerivan JS Soeldner BC Martin JH Warram CR Kahn, Proc Natl Acad Sci USA 2003 100 5 2724 9 12591951 10.1073/pnas.0438009100
17. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. AM McNeill WD Rosamond CJ Girman SH Golden MI Schmidt HE East CM Ballantyne G Heiss, Diabetes Care 2005 28 2 385 90 10.2337/diacare.28.2.385 15677797
18. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. SG Wannamethee AG Shaper L Lennon RW Morris, Arch Intern Med 2005 165 22 2644 50 10.1001/archinte.165.22. 2644 16344423
19. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. D Wood G De Backer O Faergeman I Graham G Mancia K Pyorala, Blood Press 1998 7 5-6 262 9 10321437
20. Prediction of risk of coronary events in middle-aged men in the Prospective Cardiovascular Munster Study (PROCAM) using neural networks. R Voss P Cullen H Schulte G Assmann, Int J Epidemiol 2002 31 6 1253 62 10.1093/ije/31.6.1253 12540731
21. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. DM Eddy L Schlessinger R Kahn, Ann Intern Med 2005 143 4 251 64 16103469
22. Screening for Type 2 Diabetes Mellitus in Adults: Recommendations and Rationale. USPST Force, Ann Intern Med 2003 138 3 212 214 12558361
23. National level promotion of physical activity: results from England's ACTIVE for LIFE campaign. M Hillsdon N Cavill K Nanchahal A Diamond IR White, J Epidemiol Community Health 2001 55 10 755 761 11553661 10.1136/jech.55.10.755
24. Adherence to exercise programmes. Recommendations. JI Robison MA Rogers, Sports Med 1994 17 1 39 52 8153498
25. Enhancing adherence in clinical exercise trials. HA O'Neil SN Blair, Quest 2001 53 310 317
26. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. ML Dansinger JA Gleason JL Griffith HP Selker EJ Schaefer, Jama 2005 293 1 43 53 10.1001/jama.293.1.43 15632335
27. How effective are traditional dietary and exercise interventions for weight loss? WC Miller, Med Sci Sports Exerc 1999 31 8 1129 34 10.1097/00005768-199908000-00008 10449014
28. SUCCESSFUL WEIGHT LOSS MAINTENANCE. RR Wing JO Hill, Annual Review of Nutrition 2001 21 1 323 341 10.1146/annurev.nutr.21.1.323 11375440
29. High-Risk Individuals' Willingness to Pay for Diabetes Risk-Reduction Programs. FR Johnson R Manjunath CA Mansfield LJ Clayton TJ Hoerger P Zhang, Diabetes Care 2006 29 6 1351 1356 10.2337/dc05-2221 16732020
30. Integrating prevention into health care. WHO, W.H. Organization, Editor 2002
31. Drug Metabolism and Variability among Patients in Drug Response. GR Wilkinson, N Engl J Med 2005 352 21 2211 2221 10.1056/NEJMra032424 15917386
32. Mitochondrial DNA sequence polymorphism, VO2max, and response to endurance training. FT Dionne L Turcotte MC Thibault MR Boulay JS Skinner C Bouchard, Med Sci Sports Exerc 1993 25 7 766 74 10.1249/00005768-199307000-00002 8350696
33. Individual differences in the responses to endurance and resistance training. AJ Hautala AM Kiviniemi TH Makikallio H Kinnunen S Nissila HV Huikuri MP Tulppo, Eur J Appl Physiol 2006 96 5 535 42 10.1007/s00421-005-0116-2 16369817
34. A dietary approach to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) Study. FM Sacks LJ Appel TJ Moore E Obarzanek WM Vollmer LP Svetkey GA Bray TM Vogt JA Cutler MM Windhauser PH Lin N Karanja, Clin Cardiol 1999 22 7 Suppl III6 10 10410299
35. Salt Sensitivity, a Determinant of Blood Pressure, Cardiovascular Disease and Survival. V Franco S Oparil, J Am Coll Nutr 2006 25 3 Suppl 247S 255S 16772636
36. Individual variability following 12 weeks of supervised exercise: identification and characterization of compensation for exercise-induced weight loss. NA King M Hopkins P Caudwell RJ Stubbs JE Blundell, Int J Obes (Lond) 2007 32 1 177 184 17848941 10.1038/sj.ijo.0803712
37. The metabolically healthy but obese individual presents a favorable inflammation profile. AD Karelis M Faraj JP Bastard DH St-Pierre M Brochu D Prud'homme R Rabasa-Lhoret, J Clin Endocrinol Metab 2005 90 7 4145 50 10.1210/jc.2005-0482 15855252
38. The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering: Prevalence and Correlates of 2 Phenotypes Among the US Population (NHANES 1999-2004). RP Wildman P Muntner K Reynolds AP McGinn S Rajpathak J Wylie-Rosett MR Sowers, Arch Intern Med 2008 168 15 1617 1624 10.1001/archinte.168.15.1617 18695075
39. Metabolic and Body Composition Factors in Subgroups of Obesity: What Do We Know? AD Karelis DH St-Pierre F Conus R Rabasa-Lhoret ET Poehlman, J Clin Endocrinol Metab 2004 89 6 2569 2575 10.1210/jc.2004-0165 15181025
40. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. WH Hernan M Brandle P Zhang DF Williamson MJ Matulik RE Ratner JM Lachin MM Engelgau, Diabetes Care 2003 26 1 36 47 12502656 10.2337/diacare.26.1.36
41. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. WH Herman TJ Hoerger M Brandle K Hicks S Sorensen P Zhang RF Hamman RT Ackermann MM Engelgau RE Ratner, Ann Intern Med 2005 142 5 323 32 15738451
42. Health at a Glance: OECD Indicators 2005. OECD, OECD 2005
43. Physical activity and coronary heart disease in men: The Harvard Alumni Health Study. HD Sesso RS Paffenbarger Jr IM Lee, Circulation 2000 102 9 975 80 10961960
44. A meta-analysis of physical activity in the prevention of coronary heart disease. JA Berlin GA Colditz, Am J Epidemiol 1990 132 4 612 28 2144946
45. The efficacy of behavioral interventions to modify dietary fat and fruit and vegetable intake: a review of the evidence. AS Ammerman CH Lindquist KN Lohr J Hersey, Prev Med 2002 35 1 25 41 10.1006/pmed.2002.1028 12079438
46. The Medi-RIVAGE study: reduction of cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet. S Vincent-Baudry C Defoort M Gerber MC Bernard P Verger O Helal H Portugal R Planells P Grolier MJ Amiot-Carlin P Vague D Lairon, Am J Clin Nutr 2005 82 5 964 71 16280426
47. Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors. CK Roberts C Ng S Hama AJ Eliseo RJ Barnard, J Appl Physiol 2006 101 6 1727 32 10.1152/japplphysiol.00345.2006 16902063
48. Cardiovascular disease: optimal approaches to risk factor modification of diet and lifestyle. D Forman BE Bulwer, Curr Treat Options Cardiovasc Med 2006 8 1 47 57 10.1007/s11936-006-0025-7 16401383
49. Primary Prevention of Stroke by Healthy Lifestyle. SE Chiuve KM Rexrode D Spiegelman G Logroscino JE Manson EB Rimm, Circulation 2008 118 9 947 954 18697819 10.1161/CIRCULATIONAHA.108.781062
50. What do we mean by adherence to treatment and advice for living with diabetes? A review of the literature on definitions and measurements. H Hearnshaw A Lindenmeyer, Diabet Med 2006 23 7 720 8 10.1111/j.1464-5491.2005. 01783.x 16842475
51. National type 2 diabetes prevention programme in Finland: FIN-D2D. T Saaristo M Peltonen S Keinanen-Kiukaanniemi M Vanhala J Saltevo L Niskanen H Oksa E Korpi-Hyovalti J Tuomilehto, Int J Circumpolar Health 2007 66 2 101 12 17515250
52. [Prevention of type 2 diabetes mellitus. Position paper of the National Action Forum for Diabetes Mellitus]. H Hauner R Landgraf J Schulze J Spranger E Standl, Dtsch Med Wochenschr 2005 130 17 1053 4 10.1055/s-2005-866797 15841418
53. The European perspective of type 2 diabetes prevention: diabetes in Europe-prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. PE Schwarz J Lindstrom K Kissimova-Scarbeck Z Szybinski NC Barengo M Peltonen J Tuomilehto, Exp Clin Endocrinol Diabetes 2008 116 3 167 72 10.1055/s-2007-992115 18350480